327 related articles for article (PubMed ID: 19409780)
1. Discovery of aminoheterocycles as a novel beta-secretase inhibitor class: pH dependence on binding activity part 1.
Stachel SJ; Coburn CA; Rush D; Jones KL; Zhu H; Rajapakse H; Graham SL; Simon A; Katharine Holloway M; Allison TJ; Munshi SK; Espeseth AS; Zuck P; Colussi D; Wolfe A; Pietrak BL; Lai MT; Vacca JP
Bioorg Med Chem Lett; 2009 Jun; 19(11):2977-80. PubMed ID: 19409780
[TBL] [Abstract][Full Text] [Related]
2. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.
Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L
Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
[TBL] [Abstract][Full Text] [Related]
5. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
[TBL] [Abstract][Full Text] [Related]
6. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel warhead against beta-secretase through fragment-based lead generation.
Geschwindner S; Olsson LL; Albert JS; Deinum J; Edwards PD; de Beer T; Folmer RH
J Med Chem; 2007 Nov; 50(24):5903-11. PubMed ID: 17985861
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preliminary evaluation of peptidomimetic inhibitors of human beta-secretase.
Niu Y; Wang Y; Zou X; Yang X; Ma C; Lü Y; Zhou B; Yuan Y; Du G; Xu P
Eur J Med Chem; 2010 May; 45(5):2089-94. PubMed ID: 20153560
[TBL] [Abstract][Full Text] [Related]
9. Discovery of pyrrolidine-based β-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency.
Stachel SJ; Steele TG; Petrocchi A; Haugabook SJ; McGaughey G; Katharine Holloway M; Allison T; Munshi S; Zuck P; Colussi D; Tugasheva K; Wolfe A; Graham SL; Vacca JP
Bioorg Med Chem Lett; 2012 Jan; 22(1):240-4. PubMed ID: 22130130
[TBL] [Abstract][Full Text] [Related]
10. Discovery of oxadiazoyl tertiary carbinamine inhibitors of beta-secretase (BACE-1).
Rajapakse HA; Nantermet PG; Selnick HG; Munshi S; McGaughey GB; Lindsley SR; Young MB; Lai MT; Espeseth AS; Shi XP; Colussi D; Pietrak B; Crouthamel MC; Tugusheva K; Huang Q; Xu M; Simon AJ; Kuo L; Hazuda DJ; Graham S; Vacca JP
J Med Chem; 2006 Dec; 49(25):7270-3. PubMed ID: 17149856
[TBL] [Abstract][Full Text] [Related]
11. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE).
Boy KM; Guernon JM; Shi J; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Marcinkeviciene J; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Lentz KA; Bronson JJ; Olson RE; Macor JE; Thompson LA
Bioorg Med Chem Lett; 2011 Nov; 21(22):6916-24. PubMed ID: 21782431
[TBL] [Abstract][Full Text] [Related]
12. Identification of a small molecule beta-secretase inhibitor that binds without catalytic aspartate engagement.
Steele TG; Hills ID; Nomland AA; de León P; Allison T; McGaughey G; Colussi D; Tugusheva K; Haugabook SJ; Espeseth AS; Zuck P; Graham SL; Stachel SJ
Bioorg Med Chem Lett; 2009 Jan; 19(1):17-20. PubMed ID: 19036583
[TBL] [Abstract][Full Text] [Related]
13. A conformational constraint improves a beta-secretase inhibitor but for an unexpected reason.
Hills ID; Holloway MK; de León P; Nomland A; Zhu H; Rajapakse H; Allison TJ; Munshi SK; Colussi D; Pietrak BL; Toolan D; Haugabook SJ; Graham SL; Stachel SJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):4993-5. PubMed ID: 19640712
[TBL] [Abstract][Full Text] [Related]
14. Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.
Nowak P; Cole DC; Aulabaugh A; Bard J; Chopra R; Cowling R; Fan KY; Hu B; Jacobsen S; Jani M; Jin G; Lo MC; Malamas MS; Manas ES; Narasimhan R; Reinhart P; Robichaud AJ; Stock JR; Subrath J; Svenson K; Turner J; Wagner E; Zhou P; Ellingboe JW
Bioorg Med Chem Lett; 2010 Jan; 20(2):632-5. PubMed ID: 19959359
[TBL] [Abstract][Full Text] [Related]
15. Application of fragment screening by X-ray crystallography to beta-secretase.
Murray CW; Callaghan O; Chessari G; Cleasby A; Congreve M; Frederickson M; Hartshorn MJ; McMenamin R; Patel S; Wallis N
J Med Chem; 2007 Mar; 50(6):1116-23. PubMed ID: 17315856
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
[TBL] [Abstract][Full Text] [Related]
17. Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tethering.
Yang W; Fucini RV; Fahr BT; Randal M; Lind KE; Lam MB; Lu W; Lu Y; Cary DR; Romanowski MJ; Colussi D; Pietrak B; Allison TJ; Munshi SK; Penny DM; Pham P; Sun J; Thomas AE; Wilkinson JM; Jacobs JW; McDowell RS; Ballinger MD
Biochemistry; 2009 Jun; 48(21):4488-96. PubMed ID: 19284778
[TBL] [Abstract][Full Text] [Related]
18. Design of potent inhibitors of human beta-secretase. Part 1.
Freskos JN; Fobian YM; Benson TE; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Moon JB; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
Bioorg Med Chem Lett; 2007 Jan; 17(1):73-7. PubMed ID: 17046251
[TBL] [Abstract][Full Text] [Related]
19. Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes.
Sandgren V; Agback T; Johansson PO; Lindberg J; Kvarnström I; Samuelsson B; Belda O; Dahlgren A
Bioorg Med Chem; 2012 Jul; 20(14):4377-89. PubMed ID: 22698785
[TBL] [Abstract][Full Text] [Related]
20. Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active gamma-secretase inhibitors.
McBriar MD; Clader JW; Chu I; Del Vecchio RA; Favreau L; Greenlee WJ; Hyde LA; Nomeir AA; Parker EM; Pissarnitski DA; Song L; Zhang L; Zhao Z
Bioorg Med Chem Lett; 2008 Jan; 18(1):215-9. PubMed ID: 17988864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
